Mario Rovirosa named new Ferrer CEO
Barcelona, March 2nd 2018_ Mario Rovirosa has been appointed as the new CEO of the Spanish pharmaceutical company Ferrer, effective April 1st, replacing Jordi Ramentol in the position.
With a degree in Business Administration and MBA from ESADE, Rovirosa joined Ferrer as COO Pharma in May 2016. Before his incorporation, he was Director General of Chiesi Spain, among other high-level responsibilities in companies such as Prodesfarma and Almirall.
“Mario Rovirosa has the experience, knowledge and personal characteristics necessary to carry the company forward,” says Ferrer president Sergi Ferrer-Salat. “I would like to take this opportunity to thank Jordi Ramentol for his 18 years of service to Ferrer. Thanks to his work and dedication, Ferrer is today one of the leading pharmaceutical and chemical companies in Spain. I am convinced that Mario Rovirosa is the perfect replacement to meet the challenges that the company will face in the coming years.”
For his part, Mario Rovirosa appreciates the trust placed in him by Ferrer and explains that he accepts the challenge of running the company with enthusiasm and a firm commitment to offering continuity in Ferrer. ""It is an honor to have the opportunity to lead a company with such a solid base for future growth in a sector as demanding and challenging as the chemical-pharmaceutical industry. I am sure that, in the coming years, Ferrer will reach its full potential, with the clear mission of continuing to advance the wellbeing of society.”
Jordi Ramentol maintains his connections with Ferrer as a member of the Board of Directors of the company.
Ferrer, making people better
Founded in 1959, Ferrer is a privately-held international chemical-pharmaceutical company headquartered in Barcelona. It is active throughout the full value chain, from R&D to international marketing. It is present in more than 95 countries, with 25 international affiliates. It is active in the pharmaceutical, health, fine chemical and food sectors, key areas for contributing to people’s health and wellbeing.
Since the beginning, Ferrer has been committed to the research and development of innovative medicinal products and to maintain a solid industrial structure. Ferrer’s activity across the entire healthcare spectrum includes prescription drugs, hospital products, diagnostics, vaccines, as well as fine chemicals, food and feed.